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To the Editor—We thank Dr Randal Eveland, Steris Corporation, solely to define whether FDA-cleared sterilization technologies
had the same robustness or ability to inactivate microorganisms in
the presence of organic matter and salt. Our results demonstrated
that some sterilization technologies were more “forgiving” or safe
when cleaning is not complete. Because protein (organic matter)
remains on cleaned surgical instruments,2 we must investigate at
what point the presence of protein overwhelms the ability of the steri-
lizer to inactivate contaminating microorganisms. Alternatively, we
should consider using the most robust sterilization technologies that
inactivate microorganisms in the presence of organic matter and salt
when possible.
Regarding the comparison of HPGP to VHP and materials
compatibility, there are other factors involved inmaterials compat-
ibility than the hydrogen peroxide concentration alone. Although
the theoretical concentration of hydrogen peroxide for HPGP is
higher than for VHP (ie, 25.6 vs 9.1 mg/L hydrogen peroxide
for the HPGP and VHP, respectively), the plasma process quickly
removes the hydrogen peroxide from the load by dissociating
unreacted hydrogen peroxide into oxygen and water, eliminating
the need for aeration.3 The VHP sterilizer passes hydrogen perox-
ide through a catalytic converter where it is reduced to water and
oxygen. The HPGP system has 3 potential advantages. First,
because the plasma quickly removes the residual hydrogen perox-
ide, rather than a gradual release with VHP, theremay be improved
material compatibility and biocompatibility. However, we have not
been able to find any data on the internet or in the peer-reviewed
literature that demonstrated that VHP is more or less materials
compatible or biocompatible than HPGP. Second, regarding
environmental hydrogen peroxide levels, for both sterilizers there
were no notable emissions from the sterilizers during the cycle.
However, other investigators measured significant hydrogen per-
oxide emissions when the VHP chamber door was open compared
for his letter regarding our paper that compared the microbicidal 
activity of low-temperature sterilization technologies (ie, vaporized 
hydrogen peroxide [VHP], ethylene oxide [ETO], and hydrogen 
peroxide gas plasma [HPGP]) to steam sterilization in the presence 
of salt and serum to simulate inadequate precleaning.1 As noted in 
our paper, the literature contains a paucity of information on the 
comparative microbicidal activity of the sterilization technologies 
cleared by the Food and Drug Administration (FDA) for sterilizing 
medical and surgical devices. We believe that the data from this 
study will help clinicians in infection prevention assess the robust-
ness of healthcare sterilization technologies and the risk of infec-
tion to patients when an uncleaned instrument is unintentionally 
brought into the operating room or used on a patient.
We agree with Dr Eveland there are differences in concentration 
and duration of the VHP and HPGP cycles. Our experiments com-
pared the microbicidal activity of FDA-cleared, low-temperature 
sterilization technologies to steam sterilization in the presence of salt 
and serum. The addition of salt and serum simulated inadequate 
cleaning of instruments prior to sterilization. We evaluated the 
“robustness” of sterilization technology that is used by hospitals 
throughout the United States. Robustness is defined as the ability 
to withstand and overcome adverse conditions or rigorous testing.
Concerning plasma in the HPGP technology, our intention was 
not to define the components of the cycle that created the robustness 
(eg, higher concentrations of hydrogen peroxide, plasma); it was
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microbial contaminants from objects, precedes sterilization. If
instruments are not properly cleaned prior to sterilization and
are then placed in a low-temperature sterilization technology such
as VHP, there is a possibility of failure. However, the robustness of
some sterilization technology, such as steam sterilization, makes it
exceedingly unlikely that a steam-sterilized instrument will be the
source of infection. Most medical and surgical devices used in
healthcare facilities are made of materials that are heat stable
and thus are sterilized by heat, primarily steam sterilization.
The data demonstrate how important cleaning is prior to steriliza-
tion because salt and organic matter left on instruments can inter-
fere with low-temperature sterilization. These findings reinforce
the need for meticulous cleaning and for reliable and validated
cleaning monitoring methods that are predictive of microbial
contamination and infection risk.
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to the HPGP (eg, hydrogen peroxide ranging from 5 to 17 ppm for 
VHP vs ≤0.3 ppm for HPGP).3 This demonstrated that HPGP 
emits less hydrogen peroxide into the breathing zone of the oper-
ator who opens the sterilizer door to remove the load. Third, the 
higher concentration of hydrogen peroxide in the HPGP sterilizer 
is a potential safety factor, which resulted in the significantly higher 
margin of safety for HPGP vs VHP (ie, failure rate of HPGP of 1.9%
vs 76.3% for VHP).
As it pertains to FDA clearance and the test methodology, 
there are 2 issues. First, there are limitations to the effectiveness 
of sterilization technologies even though they are FDA-cleared 
and have been demonstrated to achieve a sterility assurance level 
of 10−6 under the test conditions. In our study, we assessed the 
margin of safety or robustness associated with the sterilization 
technologies currently used in healthcare facilities. Steam steriliza-
tion, which is most common and used for sterilization of instru-
ments that are heat resistant, is the most effective and robust 
sterilization technology. Salt was the principal component that 
interfered with VHP, which is likely due to the salt crystals imped-
ing the penetration of the sterilant to the microbe. Second, many 
salts (eg, most sodium, potassium and ammonium salts) are 
soluble in water and dissolve in water and are removed from sur-
gical instruments when immersed in water4; however, some salts 
are insoluble or have a low solubility in water. Some salts, such 
as calcium carbonate, can occlude microbial exposure and dra-
matically affect the time required for inactivation. For example, 
the time required for inactivation of 8.0 × 103 Bacillus subtilis 
spores by ethylene oxide (1,200 mg/L) at 54°C with unoccluded 
spores is 30 seconds, but for spores occluded in calcium carbonate, 
the inactivation time is >2 weeks.5 Additionally, to understand the 
dynamics of a cleaning process and the potential effect of soils on a 
sterilization process, the different ingredients in the soil (ie, organic 
to inorganic ratio) need to be examined independently.4
Lastly, as demonstrated by this study, not all sterilization tech-
nologies used in healthcare to sterilize surgical instruments are 
equal and have the same robustness. Although FDA-cleared 
sterilization technologies theoretically kill a very large number 
of microorganisms on instruments (eg, 12 logs or a trillion), health-
care personnel can unintentionally impede the effectiveness of 
sterilization technology by improper cleaning of the instruments 
prior to sterilization. Cleaning, or the removal of visible soil and
